Is Mycobacterium tuberculosis a life-threatening disease yet?


Creative Commons License

Özmen M. E., Akkoyunlu Y., Bozkurt Ç., Okay G., Durdu B., Aslan T.

World Academic Congress of Emergency Medicine 2023, Antalya, Türkiye, 28 - 31 Ekim 2023, cilt.1, ss.724, (Tam Metin Bildiri)

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Cilt numarası: 1
  • Basıldığı Şehir: Antalya
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.724
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Is Mycobacterium tuberculosis a life-threatening disease yet?

Tuberculosis is one of the oldest diseases, caused by Mycobacterium tuberculosis and effect every organ, especially the lungs. Although it usually has a chronic course, delayed cases may present with an acute presentation.

Case: Thirty-year-old Indian male patient applied to emergency department with complaints of headache, visual disturbance, and confusion. He came to Türkiye from India 25 days ago. Headache and visual disturbance started 15 days ago and gradually increased. Confusion developed for the last 5 days. Physical examination; he was confused, lethargic, non-cooperative, non-oriented, speaking as meaningless sounds, Glasgow Coma Scale:11, Blood presssure:149/93mmHg, Fever:37.7°C, Heart rate:144/min. Neck stiffness, Kerning and Brudzinski signs were positive. Pupillary was anisochoric, right eye was mydriatic, bilateral outward gaze limitation were observed.

Cranial magnetic resonance (MRI): bilateral frontotemporoparietal and leptomeningeal enhancements are present. Contrast enhancements were detected in bilateral 6th cranial nerve, bilateral 9th cranial nerve, prominent trigeminal nerves on the right, 7th and 8th cranial nerve traces on the left, bilateral optic nerve prechiasmatic segment and basal cisternae. In cerebrospinal fluid (CSF) examination; 12 Erythrocytes/mm3, 110 Leukocytes/mm3 (95% lymphocytes) were seen, CSF protein 276.10 mg/dL, CSF glucose 13 mg/dL (Simultaneous blood glucose: 110 mg/dL). With the diagnosis of tuberculous meningitis, standard anti-tuberculosis treatment (isoniazid 300 mg/day, rifampicin 600 mg/day, pyrazinamide 2000 mg/day, ethambutol 1500 mg/day) and dexamethasone 16 mg/day was initiated.

After the 2nd week of the treatment, the patient regained consciousness. He started to talk meaningfully and walk with support. In the control cranial MRI taken at the 3rd week of the treatment: a significant decrease in pathological contrast enhancements was observed. At the end of 40 days, Mycobacterium tuberculosis complex yielded in the CSF culture. Antibiograms of ethambutol, isoniazid, streptomicin and rifampin were found sensitive. After clinical recovery  he was discharged to complete his anti-tuberculosis treatment to 18 month. Despite recovery unfortunately bilateral vision loss remained as a sequela.

Conclusion: Tuberculous meningitis is the form of tuberculosis disease with the highest morbidity and mortality rates. The nonspecific symptoms and signs of the disease may lead delay in diagnosis. In endemic areas it should be taken in mind in nearly every differential diagnosis.

Keys: tuberculosis, meningitis, cerebrospinal fluid